15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Cerence Inc, 1 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $9.00 to $12.00, so the covering firms are broadly aligned. The average target of $10.67 sits 29% above the current $8.27. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.14 next quarter toward $0.79 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy133%
Hold267%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Cerence Inc.
As of Sep, 1 of 3 firms rate CRNC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CRNC EPS & revenue forecast
EPS · NEXT QUARTER
$0.14
Range $0.05 – $0.24 · 4 analysts · -18% YoY
Next period, 4 analysts expect Cerence Inc to earn $0.14 a share (range $0.05 – $0.24), versus $0.18 a year earlier. Full-year consensus is $0.73, growing to $0.79 the year after.
REVENUE · NEXT QUARTER
$69.8M
Range $63.2M – $73.2M · 4 analysts · -39% YoY
Revenue is expected to reach $69.8M (range $63.2M – $73.2M), -39.4% year-over-year. Full-year consensus is $312.7M, rising to $288.9M next year.
Top analysts covering Cerence Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CRNC.
#1
Mark Delaney
Goldman Sachs · Rank #57
Hold
$9.00+8.8% to target
Overall win rate
53%
+ Follow
#2
N. Quinn Bolton
Needham · Rank #127
Buy
$16.00+93.5% to target
Overall win rate
39%
+ Follow
#3
Thomas Blakey
Cantor Fitzgerald
Buy
$11.00+33.0% to target
Coverage
—
+ Follow
#4
Itay Michaeli
TD Cowen
Hold
$12.00+45.1% to target
Coverage
—
+ Follow
#5
CM
Chris McNally
Evercore ISI Group
Hold
$9.00+8.8% to target
Coverage
—
+ Follow
CRNC stock forecast FAQ
What is CRNC's average 12-month price target?+
The 3 analysts with a live target average $10.67 for Cerence Inc over the next 12 months, ranging from a $12.00 high to a $9.00 low.
Is CRNC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 1 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CRNC?+
The Street-high target is $12.00 (TD Cowen), and the Street-low is $9.00 (Goldman Sachs). The average of all 3 active targets is $10.67.
How many Wall Street analysts cover CRNC?+
3 analysts have an active rating on Cerence Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering CRNC?+
Among analysts who currently cover CRNC, Mark Delaney of Goldman Sachs has the strongest overall Quantellect track record (Rank #57). Their current call is Hold with a $9.00 target.
What is Cerence Inc's projected EPS for next quarter?+
The consensus estimate is $0.14 per share (range $0.05 – $0.24) across 4 analysts. Full-year EPS is projected at $0.73, rising to $0.79 the following year.
How much revenue is Cerence Inc expected to report next quarter?+
Consensus revenue is $69.8M (range $63.2M – $73.2M). Full-year revenue is projected at $312.7M, growing to $288.9M next year.
Have analysts been upgrading or downgrading CRNC lately?+
As of Sep, 1 of 3 firms rate CRNC a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CRNC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
